
According to Benzinga Pro, during Q1, Integra Lifesciences (NASDAQ:IART) earned $32.90 million, a 27.51% increase from the preceding quarter. Integra Lifesciences's sales decreased to $376.64 million, a 7.12% change since Q4. Integra Lifesciences earned $45.38 million, and sales totaled $405.52 million in Q4.